Evidence map›Paper›PMID 20595512›Full record

ArticleBlood2010

RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis.

Ande Satyanarayana, Kristbjorn Orri Gudmundsson, Xiu Chen, Vincenzo Coppola, Lino Tessarollo, Jonathan R Keller, Steven X Hou

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Susceptibility to Childhood Pneumonia: A Genome-Wide Analysis.American journal of respiratory cell and molecular biology · 2017
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Transcriptional and epigenetic landscape of CaJournal of cell communication and signaling · 2021
    Article
  9. Article
  10. Review
  11. Transforming Endothelium with Platelet-Rich Plasma in Engineered Microvessels.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Developmental checkpoints guarded by regulated necrosis.Cellular and molecular life sciences : CMLS · 2016
    Review
  18. Article
  19. Article
  20. Rap1 signaling in endothelial barrier control.Cell adhesion & migration · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ande SatyanarayanaMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA.
Kristbjorn Orri Gudmundsson
Xiu Chen
Vincenzo Coppola
Lino Tessarollo
Jonathan R Keller
Steven X Hou
National Cancer Institute · USCenter for Cancer Research · USFrederick National Laboratory for Cancer Research · USScience Applications International Corporation (United States) · US

Funding

Molecular-Cellular Regulation of Hematopoietic Stem CellsZIABC010001 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KELLER, JONATHAN R · 2009 to 2024
$16.8M
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell AgingZIABC010738 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HOU, STEVEN · 2009 to 2020
$14.4M
Gene Targeting FacilityZICBC011265 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TESSAROLLO, LINO · 2010 to 2025
$8.9M
Intramural NIH HHS
6 · The paper itself

Abstract

RapGEF2 is one of many guanine nucleotide exchange factors (GEFs) that specifically activate Rap1. Here, we generated RapGEF2 conditional knockout mice and studied its role in embryogenesis and fetal as well as adult hematopoietic stem cell (HSC) regulation. RapGEF2 deficiency led to embryonic lethality at ~ E11.5 due to severe yolk sac vascular defects. However, a similar number of Flk1(+) cells were present in RapGEF2(+/+) and RapGEF2(-/-) yolk sacs indicating that the bipotential early progenitors were in fact generated in the absence of RapGEF2. Further analysis of yolk sacs and embryos revealed a significant reduction of CD41 expressing cells in RapGEF2(-/-) genotype, suggesting a defect in the maintenance of definitive hematopoiesis. RapGEF2(-/-) cells displayed defects in proliferation and migration, and the in vitro colony formation ability of hematopoietic progenitors was also impaired. At the molecular level, Rap1 activation was impaired in RapGEF2(-/-) cells that in turn lead to defective B-raf/ERK signaling. Scl/Gata transcription factor expression was significantly reduced, indicating that the defects observed in RapGEF2(-/-) cells could be mediated through Scl/Gata deregulation. Inducible deletion of RapGEF2 during late embryogenesis in RapGEF2(cko/cko)ER(cre) mice leads to defective fetal liver erythropoiesis. Conversely, inducible deletion in the adult bone marrow, or specific deletion in B cells, T cells, HSCs, and endothelial cells has no impact on hematopoiesis.

Indexed as

HematopoiesisAnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell MovementCell ProliferationEmbryo, MammalianGATA Transcription FactorsGene DeletionGene Expression RegulationGuanine Nucleotide Exchange FactorsHematopoietic Stem CellsLiverMiceMice, KnockoutProto-Oncogene ProteinsBasic Helix-Loop-Helix ProteinsCNrasGEF protein, mouseGATA Transcription FactorsGuanine Nucleotide Exchange FactorsProto-Oncogene ProteinsTal1 protein, mouseT-Cell Acute Lymphocytic Leukemia Protein 1

Identifiers

PMID20595512
PMCPMC2974602
OpenAlexW2053453309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.